Posted on September 27, 2016 by Sitemaster
Despite his last blog post saying that he thought he was “done”, Bill’s still giving to us all from his wisdom and experience. He, and we, hope it will be helpful to all those battling late stage prostate cancer. Click here for earlier parts if you missed them. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cyclophosphamide, Cytoxan, Manning | 5 Comments »
Posted on December 5, 2012 by Sitemaster
The Georgia Health Sciences University in Augusta, GA, has initiated a new trial of sipuleucel-T (Provenge) in combination with cyclophosphamide and an investigational drug known as CT-011 for the treatment of chemotherapy-naive patients with progressive, metastatic, castrate-resistant prostate cancer (mCRPC). … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: castration-resistant, CT-011, cyclophosphamide, mCRPC, metastatic, sipuleucel-T | Leave a comment »
Posted on May 27, 2009 by Sitemaster
Today’s news reports cover such items as:
- Identification of prostate cancer cells in urine
- Prognosis after radiation therapy
- The effect of bisphenol A on prostate cancer therapy
- The appropriateness of primary androgen deprivation for localized prostate cancer
- Data from clinical trials of Phase II clinical trial of docetaxel + samarium-153 lexidronam and cyclophosphamide + dexamethasone in late stage disease … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ADT, androgen deprivation therapy, bisphenol A, cyclophosphamide, Diagnosis, docetaxel, primary, prognosis, risk, samarium-153 | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 